We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
INTEGRA BIOSCIENCES AG

Download Mobile App




Immunoassay Analyzer POC Diagnostic Tool for Venous Thromboembolism

By LabMedica International staff writers
Posted on 07 Jun 2011
A compact and cost-effective point of care (POC) immunoassay analyzer offers rapid turnaround times for determination of critical biomarkers, such as D-dimer, and provides a valuable diagnostic tool for ruling out venous thromboembolism (VTE).

The easy-to-use AQT90 FLEX can simultaneously measure cardiac markers, coagulation markers, infection markers, and pregnancy markers from a single sample. More...
No sample preparation is required, and, as a closed tube system, the risk of users coming into contact with blood or waste products is eliminated.

A product of Radiometer (Crawley, United Kingdom), the compact, cost-effective AQT90 FLEX enables clinicians to perform rapid, accurate, POC D-dimer measurements in less than 20 minutes. AQT90 FLEX delivers complete data capture with continuous synchronization of analyzers and laboratory information systems/hospital information systems (LIS/HIS).

The Radiance software solution provides complete remote control that emulates the data control and flow of a central laboratory, with the potential to encompass multiple hospitals within a region.

Reports have estimated that 25,000 people die annually as a result of VTE, and that more than 10,000 lives could be saved if all patients were screened on admission to hospital. Patients with negative D-dimer test results are at very low risk of VTE. Rapid point-of-care testing with the AQT90 FLEX saves time and reduces costs by improving patient flow and decreasing the number of unnecessary procedures requested.

Related Links:

Radiometer


Platinum Member
ADAMTS-13 Protease Activity Test
ATS-13 Activity Assay
Verification Panels for Assay Development & QC
Seroconversion Panels
Complement 3 (C3) Test
GPP-100 C3 Kit
Gold Member
Melanoma Panel
UltraSEEK Melanoma Panel
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: QIP-MS could predict and detect myeloma relapse earlier compared to currently used techniques (Photo courtesy of Adobe Stock)

Mass Spectrometry-Based Monitoring Technique to Predict and Identify Early Myeloma Relapse

Myeloma, a type of cancer that affects the bone marrow, is currently incurable, though many patients can live for over 10 years after diagnosis. However, around 1 in 5 individuals with myeloma have a high-risk... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Technology

view channel
Image: Ziyang Wang and Shengxi Huang have developed a tool that enables precise insights into viral proteins and brain disease markers (Photo courtesy of Jeff Fitlow/Rice University)

Light Signature Algorithm to Enable Faster and More Precise Medical Diagnoses

Every material or molecule interacts with light in a unique way, creating a distinct pattern, much like a fingerprint. Optical spectroscopy, which involves shining a laser on a material and observing how... Read more

Industry

view channel
Image: The collaboration aims to leverage Oxford Nanopore\'s sequencing platform and Cepheid\'s GeneXpert system to advance the field of sequencing for infectious diseases (Photo courtesy of Cepheid)

Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions

Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.